DK0411736T3 - 11beta-substituerede 16alfa,17alfa-methylen-østra-4,9-dien-3-oner - Google Patents

11beta-substituerede 16alfa,17alfa-methylen-østra-4,9-dien-3-oner

Info

Publication number
DK0411736T3
DK0411736T3 DK90250202.0T DK90250202T DK0411736T3 DK 0411736 T3 DK0411736 T3 DK 0411736T3 DK 90250202 T DK90250202 T DK 90250202T DK 0411736 T3 DK0411736 T3 DK 0411736T3
Authority
DK
Denmark
Prior art keywords
substituted
group
methylene
ones
alkyl
Prior art date
Application number
DK90250202.0T
Other languages
English (en)
Inventor
Helmut Dr Kasch
Reimar Dr Krieg
Anatoli Kurischko
Kurt Prof Dr Ponsold
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DD33148189A external-priority patent/DD289536A5/de
Priority claimed from DD33181989A external-priority patent/DD289538A5/de
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0411736T3 publication Critical patent/DK0411736T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90250202.0T 1989-08-04 1990-08-06 11beta-substituerede 16alfa,17alfa-methylen-østra-4,9-dien-3-oner DK0411736T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD33148189A DD289536A5 (de) 1989-08-04 1989-08-04 Verfahren zur herstellung von 17-alkoxy-11beta-aryl-16alpha, 17alpha-methylen-gona-4,9-dienen
DD33181989A DD289538A5 (de) 1989-08-16 1989-08-16 Verfahren zur herstellung von 11 beta-substituierten 16 alpha, 17 alpha-methylen-gona-4,9-dienen

Publications (1)

Publication Number Publication Date
DK0411736T3 true DK0411736T3 (da) 1994-09-19

Family

ID=25748291

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90250202.0T DK0411736T3 (da) 1989-08-04 1990-08-06 11beta-substituerede 16alfa,17alfa-methylen-østra-4,9-dien-3-oner

Country Status (8)

Country Link
US (1) US5162312A (da)
EP (1) EP0411736B1 (da)
JP (1) JP3135564B2 (da)
AT (1) ATE105299T1 (da)
DE (1) DE59005594D1 (da)
DK (1) DK0411736T3 (da)
ES (1) ES2053091T3 (da)
WO (1) WO1991001994A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0683172B1 (en) * 1994-05-19 1997-08-13 Akzo Nobel N.V. 11,21-Bisphenyl-19-norpregnane derivatives
ES2152671T3 (es) * 1996-05-01 2001-02-01 Us Gov Health & Human Serv Derivados de progesterona sustituidos en posicion 21 como nuevos agentes antiprogestacionales.
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
DE19917979A1 (de) * 1999-04-21 2000-10-26 Clariant Gmbh Verfahren zur Herstellung von substituierten Phenyl-boronsäuren
CA2680119A1 (en) * 2007-03-07 2008-09-12 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators
ES2378604T3 (es) 2009-05-22 2012-04-16 HEYL Chemisch-Pharmazeutische Fabrik GmbH und Co. KG Método para la síntesis de dienogest a partir de 3-metiléter de estrona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646074A (en) * 1969-11-26 1972-02-29 Searle & Co 3 17-dioxygenated 16alpha 17alpha-methano-5alpha-androstanes and unsaturated congeners
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
JPH05509287A (ja) 1993-12-22
ES2053091T3 (es) 1994-07-16
JP3135564B2 (ja) 2001-02-19
EP0411736B1 (de) 1994-05-04
DE59005594D1 (de) 1994-06-09
US5162312A (en) 1992-11-10
WO1991001994A1 (de) 1991-02-21
ATE105299T1 (de) 1994-05-15
EP0411736A1 (de) 1991-02-06

Similar Documents

Publication Publication Date Title
OA09468A (fr) Nouveaux dérivés du 1,2-benzisoxazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ATE132144T1 (de) Chalkonderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
FI823923A0 (fi) Antifibrinolytiskt aktiva foereningar
DK0411736T3 (da) 11beta-substituerede 16alfa,17alfa-methylen-østra-4,9-dien-3-oner
IL80619A0 (en) 3-oxadiazole and 3-carboxylic acid ester beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ATE53032T1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
DE3850603D1 (de) Arylaralkylether, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung.
ES2053090T3 (es) Antigestagenos 11beta-aril-16alfa,17alfa-ciclohexano-estra-4,9-dienos.
ATE193531T1 (de) Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten
ATE107298T1 (de) 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE59647T1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE25523T1 (de) Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE68906827D1 (de) Phenothiazinderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE180406T1 (de) Erythromycinderivate
ATE18223T1 (de) Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
JPS56131551A (en) Tyrosine derivative and medicinal use
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
DE69308757D1 (de) 1-Phenybicyclo-2,2,2-oktanderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
ATE130309T1 (de) 14alpha,16alpha-ethano- und 14alpha,16alpha- ethenoestratriene.